Eva M. del Amo
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems 7
- Ophthalmology top 1%
- Retinal Diseases and Treatments 18
- Glaucoma and retinal disorders 9
- Biochemistry top 5%
-
- Retinal and Macular Surgery 7
-
- Ocular Surface and Contact Lens 9
-
- Retinal Development and Disorders 8
- Protein Interaction Studies and Fluorescence Analysis 8
-
- Drug Transport and Resistance Mechanisms 7
- Co-authors
- Arto UrttiMarika RuponenMarjo YliperttulaKati‐Sisko VellonenHeidi KidronElisa ToropainenAstrid SubriziVeli‐Pekka Ranta
- Journals
- European Journal of Pharmaceutical Sciences (7 papers)European Journal of Pharmaceutics and Biopharmaceutics (6 papers)Molecular Pharmaceutics (4 papers)
- Partner nations
- FinlandRussiaUnited Kingdom
In The Last Decade
Eva M. del Amo
40 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 102
- Pharmaceutical Science 455
- Ophthalmology 653
- Biochemistry 132
- Radiology, Nuclear Medicine and Imaging 416
- Public Health, Environmental and Occupational Health 418
Countries citing papers authored by Eva M. del Amo
This map shows the geographic impact of Eva M. del Amo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva M. del Amo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva M. del Amo more than expected).
Fields of papers citing papers by Eva M. del Amo
This network shows the impact of papers produced by Eva M. del Amo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva M. del Amo. The network helps show where Eva M. del Amo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eva M. del Amo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 3 | |
| 6 | 2022 | 33 | |
| 7 | 2020 | 86 | |
| 8 | 2020 | 13 | |
| 9 | 2020 | 30 | |
| 10 | 2019 | 177 | |
| 11 | 2018 | 104 | |
| 12 | 2017 | 46 | |
| 13 | 2017 | 31 | |
| 14 | 2017 | 92 | |
| 15 | 2016 | 43 | |
| 16 | 2015 | 86 | |
| 17 | 2015 | 113 | |
| 18 | 2015 | 181 | |
| 19 | 2012 | 30 | |
| 20 | 2008 | 252 |
About Eva M. del Amo
Eva M. del Amo is a scholar working on Ophthalmology, Pharmaceutical Science and Radiology, Nuclear Medicine and Imaging, having authored 41 papers that have together received 1.8k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (18 papers), Glaucoma and retinal disorders (9 papers), Ocular Surface and Contact Lens (9 papers), Retinal Development and Disorders (8 papers), Protein Interaction Studies and Fluorescence Analysis (8 papers), Drug Transport and Resistance Mechanisms (7 papers), Retinal and Macular Surgery (7 papers) and Advanced Drug Delivery Systems (7 papers). The work is most often cited by research in Pharmaceutical Science (455 citations), Ophthalmology (653 citations) and Biochemistry (132 citations). Eva M. del Amo has collaborated with scholars based in Finland, Russia and United Kingdom. Frequent co-authors include Arto Urtti, Marika Ruponen, Marjo Yliperttula, Kati‐Sisko Vellonen, Heidi Kidron, Elisa Toropainen, Astrid Subrizi, Veli‐Pekka Ranta, Viktor Korzhikov‐Vlakh and Tatiana Tennikova. Their work appears in journals such as European Journal of Pharmaceutical Sciences, European Journal of Pharmaceutics and Biopharmaceutics, Molecular Pharmaceutics, International Journal of Pharmaceutics and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.